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ABSTRACT
Breast cancer may progress from an atypical lesion. Angiogenesis has an important role in the
growth, invasion and metastasis of breast cancer, which can be reflected through the microvascular
density (MVD). Tumor associated macrophages (TAMs) are stromal cells that can produce pro-
angiogenic factor such as vascular endothelial growth factor (VEGF), and induce matrix
metalloproteinase-9 (MMP-9) for degrading extracellular matrix and basement membrane.
Angiogenesis in breast cancer progression and its relationship with histological grading as well
as its staging need to be defined and thus, cancer therapy and prognosis can be determined
more accurately. The aim of this study was to investigate the correlation between TAM, MVD,
VEGF and MMP-9 expressions among fibrocystic lesion, atypical lesion and breast cancer, and
its correlation with histological grading and staging of breast cancer. Using a cross-sectional
study, a total of 50 paraffin embedded tissues of fibrocystic lesion, atypical lesion and breast
cancer were chosen in this study. Those specimens were stained immunohistochemically with
monoclonal antibody (MoAb) anti CD68, von Willebrand factor (vWF), VEGF and MMP-9. The
expressions of VEGF and MMP-9 were counted from the mean numbers of positive tumor cells.
TAMs were counted from numbers of macrophages which expressed CD-68. MVDs were counted
from numbers of microvessels whose endothelial cells expressed vWF, using the Average
Microvessels Count ( AMC) method. The correlation of both markers and different type of breast
lesions were analyzed by using Pearson correlation. There were statistically significant correlations
between TAM (r=0.760; p=0.000), MVD (r=0.659; p=0.000), and MMP-9 (r=0.518; p=0.000),
among several breast lesions and histological grade of breast cancer. The highest of their
expressions was found in the poor grade of cancers. There were statistically significant correlations
between TAM (r=0.581; p=0.000), VEGF (r=0.443; p=0.001) and MVD (r=0.566; p=0.000)
among fibrocystic, atypical lesion and stage II - III of breast cancer. VEGF expression was not
significantly correlated with several histological grade of breast cancer and the highest of its
expression was only found in atypical lesion. This study has suggested that TAM, MVD, VEGF
and MMP-9 expressions might play an important role in the histological progression, histological
grading and staging of breast cancer. The highest expression of VEGF in atypical breast lesion
supported the fact that angiogenic switch already started in the early stage and grade of breast
cancer.
ABSTRAK
Karsinoma payudara dapat berkembang dari lesi fibrokistik dengan proliferasi atipi sel epitel.
Angiogenesis berperan penting dalam perkembangan, invasi dan metastasis karsinoma payudara
dan proses tersebut ditunjukkan dari jumlah kepadatan mikrovaskular (MVD). Tumor associated
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macrophages (TAMs) adalah sel radang di dalam stroma yang dapat menghasilkan faktor pro-
angiogenik seperti VEGF, dan memacu MMP-9 untuk mendegradasi matriks ekstraselular dan
membran basal. Angiogenesis pada karsinoma payudara dan hubungannya dengan derajat histologis
serta stadium perlu diteliti agar terapi dan prognosis karsinoma dapat ditentukan lebih tepat.
Penelitian ini bertujuan mengkaji korelasi antara TAM, MVD, ekspresi VEGF dan MMP-9 antara
lesi fibrokistik, lesi atipi dan karsinoma payudara, serta korelasinya dengan derajat histologis dan
stadium. Dengan uji cross-sectional, diteliti 50 blok parafin dari lesi fibrokistik, lesi atipi dan
karsinoma payudara. Spesimen dicat dengan metode imunohistokimiawi dengan MoAb anti
CD68, vWF, VEGF dan MMP-9. Ekspresi VEGF dan MMP-9 dihitung dari jumlah sel karsinoma
yang positif mengekspresikan marker tersebut. TAMs dihitung dari jumlah makrofag yang
mengekspresikan CD68. MVD ditentukan dari jumlah mikrovaskular yang sel endotelnya meng-
ekspresikan vWF, dan ditentukan dengan metode Average Microvessels Count ( AMC). Korelasi
antara marker-marker tersebut dengan berbagai tipe lesi payudara dan dengan berbagai derajat
histologis serta stadium dianalisis dengan korelasi Pearson. Hasil penelitian menunjukkan adanya
korelasi bermakna antara TAM (r=0,760; p=0,000), MVD (r=0,659; p=0,000), MMP-9 (r=0,518;
p=0,000) dengan berbagai lesi payudara dan derajat histologis karsinoma. Ekspresi tertinggi
marker tersebut didapatkan pada karsinoma derajat histologis buruk. Didapatkan korelasi bermakna
antara TAM (r=0,581, p=0,000), VEGF (r=0,443; p=0,001) dan MVD (r=0,566; p=0,000)
antara lesi fibrokistik, lesi atipi dan karsinoma stadium II-III. Ekspresi VEGF tidak berkorelasi
dengan derajat histologis karsinoma, namun ekspresi tertinggi VEGF didapatkan pada lesi atipi.
Dari penelitian ini disimpulkan bahwa TAM, MVD, ekspresi VEGF dan MMP-9 berperan penting
pada perkembangan, derajat histologis dan stadium karsinoma payudara. Ekspresi tinggi VEGF
pada lesi atipi menunjukkan bahwa angiogenic switch sudah dimulai sejak awal stadium dan
derajat histologis karsinoma payudara.
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INTRODUCTION
Invasive duct carcinoma is the most
common type of breast cancer and it may derive
from fibrocystic lesion, especially with atypical
proliferation of epithelial cells. There is a
significant correlation between the degree of
cell proliferation and its progression into in situ
and invasive carcinoma.1,2 Histological grading
of this cancer is classified into well, moderate
and poor grade, based on the tubular formation,
number of mitosis and cell pleomorphism. Many
studies show that there is a correlation between
histological grading and prognosis.1 Prognosis
of breast cancer is also determined by its staging
that consists of tumor size, number of lymph-
nodes involved and distant metastasis. In
Yogyakarta Special Region, Indonesia 70% of
breast cancer is found in stage III B, poorly
differentiated and with 38% already having
metastasis of more than 3 lymph-nodes.3
Breast cancer progression depends on
vascularization. Cancer cannot enlarge beyond
1 to 2 mm in diameter or thickness unless they
are vascularized. There are some factors that
influence the angiogenesis process, such as
tumor associated macrophages (TAMs).4 TAMs
are a group of leucocytes that belong to the
mononuclear phagocytes. TAMs are derived
from monocyte and then differentiated further
into resident tissue macrophages.5 In the setting
of tumors, TAMs have pleiotrophic functions,
which can influence tumor growth, both in terms
of progression and regression. This differential
effect of TAMs is believed to be regulated by
modulation of the host immune system. Tumor
growth reduction by TAMs can be mediated by
non-specific antitumor cytotoxic mechanisms or
induction of specific cell lytic effects. On the
other hand, as the effect of tumor progression,
TAMs produce growth factors that promote
cancer cell proliferation and dissemination, and
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enhance angiogenesis.6,7 The most important
tumor growth factor is vascular endothelial
growth factor (VEGF) which can induce
proliferation and maturation of endothelial
cells.8 VEGF can attract TAMs into the hypoxic
tumor areas.9 The expression of TAMs can be
detected with monoclonal antibody against
CD68.
TAM and VEGF can induce microvascular
density (MVD). MVD is highlighted by staining
endothelial cells for von Willebrand factor
(vWF)-related staining. MVD indicates
representative angiogenesis of the tumor. The
expression of MVD is higher in breast cancer
than in benign lesion and the height of MVD is
correlated with metastasis and worse
prognosis.10 TAM and tumor cells can produce
a proteolytic enzyme, matrix metalloproteinase-
9 (MMP-9), that has an important role in tumor
cells invasion to the basement membrane and
stroma, blood vessel penetration, and
metastasis. MMP-9 has also been implicated
in the process of angiogenesis both as the
inhibitor and the activator.4
Many studies have proven that interaction
of TAMs and tumor cells is important as the
new alternative marker and treatment of cancer.
Thyroid cancer with high TAMs expression has
a better prognosis compared to the lower one.11
In prostatic cancer, there is a reverse correlation
between the number of TAMs and clinical stage,
and it seems that the decrease of total number
of TAMs can be used as a new prognostic
marker.12 In melanoma maligna, the high number
of total TAMs is statistically correlated with
worse treatment responses.13 In a breast cancer
mouse model, vaccin legumin-based DNA can
induce cytotoxic T cell (CD8) that can decrease
the density of TAMs and restrain TAMs to
produce pro-angiogenic factors.14 However, the
role of angiogenesis in relation with tumor
progressivity, histological grading and staging
of breast cancer remains unclear.
This study aimed to investigate the
correlation between different tumor markers
(TAM, MVD, VEGF, MMP-9) and different
types of breast lesions (fibrocystic lesion,
atypical lesion and breast cancer of different
stages and histological grading).
MATERIALS AND METHODS
The design of this study was a quantitative
non-experimental, performed by cross sectional
method. Samples of this study were paraffin-
embeded tissue of fibrocystic lesion, atypical
lesion and breast cancer, which had been taken
from Department of Anatomical Pathology,
Faculty of Medicine/Dr. Sardjito General
Hospital, Universitas Gadjah Mada,Yogyakarta,
in the year 2008. Histological grading of cancer
was classified based on the Ellis and Elston
criteria into well, moderate and poor grade.1
Staging of cancer was grouped into stage I-IV
based on the TNM classification.
The specimens were stained immunohisto-
chemically with monoclonal antibody (MoAb)
anti CD68 (524H12 Novocastra, dilution 1:100),
MoAb anti vWF (36B11 Novocastra, dilution
1:50), PoAb anti VEGF (clone:RB-9031
Neomaker, Lab Vision) and PoAb anti MMP-9
(Neomaker, Lab vision, dilution 1:200) using
chromogen DAB and counter stained
Hematoxyllin Mayer. The expressions of VEGF
and MMP-9 were counted from mean number
of cytoplasmic positive tumor cells/100 tumor
cells in 5 microscopic fields. Numbers of TAM
were counted from number of macrophages
which expressed CD68 in the 5 hot spot areas.
MVD was counted from the number of
microvascular whose endothelial cells
expressed vWF, using the average microvessels
count (AMC) method. This method counted the
average microvessel count per square
millimeter and recorded the number of
microvessels in the area along border between
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cancer nests and the stroma.15 Immunohisto-
chemical results were analyzed by two
independent observers.
The correlation of mean number of TAM,
MVD, VEGF and MMP-9 with different types
of breast lesions (fibrocystic lesion, atypical
lesion and breast cancer of different stages and
histological grading) was analyzed with
Pearson Correlation test.
RESULTS
The characteristic of samples
Fifty breast cancer specimens were used
in this study. These samples consisted of 10
fibrocystic lesion, 10 atypical lesion and 30 well
grade breast cancer (8 samples), moderate
grade (11 samples), and poor grade (11
samples). Based on the cancer stage, 13 samples
belonged to stage II, 15 samples to stage III and
2 samples to stage IV. There was no sample of
breast cancer for stage I.
FIGURE 1 shows the TAMs expressions
among CD68 positive cells, cytoplasmic cancer
cell’s VEGF expressions, MVD showed by
endothelial vWF cells expressions and
cytoplasmic cancer cell’s MMP-9 expressions
obtained by immunohistological examination
from breast cancer specimens with 400x
magnification.
TABLE 1 shows statistically significant
correlations between TAM, MVD and MMP-9
expressions (p<0.05) among fibrocystic lesion,
atypical lesion and breast cancer of well,
moderate and poor grade respectively. The
highest of their expressions was found in the
poor grade cancer. VEGF expression showed
no significant correlation with different type of
breast lesions, and the highest VEGF expression
was found in atypical lesion.
FIGURE 1. A. TAMs Expressions among CD 68 Positive Cells (magnification 400x); B.
Cytoplasmic Cancer Cell’s VEGF Expressions (magnification 400x); C. MVD
showed by endothelial vWF cells expressions (magnification 400x); D.
Cytoplasmic Cancer Cell’s MMP-9 Expressions (magnification 400x).
A B
C D
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TABLE 1. Correlation of mean number of TAM, MVD, VEGF and MMP-9 expressions among fibrocystic
lesion, atypical lesion and several histological grading of breast cancer
TABLE 2 shows statistically significant
correlation between TAM, MVD, and VEGF
expressions (p<0.05), among several stage of
breast lesions. The highest expression of TAM
and MVD was found in stage III of breast cancer,
while the highest expression of VEGF was
found in fibrocystic and atypical lesions.
TABLE 2. Correlation of mean expression of TAM, MVD, VEGF and MMP-9 among fibrocystic and atypical
lesion, stage II and III of breast cancer
DISCUSSION
The most common types of breast cancer in
this study were cancers with moderate and poor
histological grade, as well as stage III cancer.
There were no cases of cancer stage I. This
means that breast cancer cases studied were
mostly in the late stage and high grade. This
result is similar to that of a previous study in
Yogyakarta Special Region.3
This study showed that TAM, MVD and
MMP-9 expressions were significantly higher
in breast cancer than in fibrocystic and atypical
lesion. It was indicated that the highest of their
protein expressions, the highest of cancers grade
and stage were observed (TABLE 1 and 2). This
result suggests that TAM, MVD and MMP-9
expressions have an important role in the
histological progression, histological grading
and staging of breast cancer. The MVD and
TAM were counted in the hot spot areas, which
is biologically important because they provide
a route through which tumor cells can
metastasis. Hot spot areas may include necrosis
and hypoxia. Hypoxic cells release bFGF and
HIF1-which can attract TAM to those areas.
TAM can induce proliferation, migration and
differentation of endothelial cells4,9 and so as
to induce angiogenesis.
TAM plays a role in the immune response
via the elaboration of cytokines and growth
factors. The presence of TAM has been reported
to be in various tumors including breast cancer.
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TAMs are recruited to tumors through the local
expression of potent chemoattractants, such as
colony stimulating factor-1 (CSF-1) and
macrophages chemoattractant protein-1
(MCP1). Increased MCP1 was proven to
correlate with increased TAM.7 Astudy in breast
cancer shows that high expressions of MCP1
can be used as an indicator of early relapse,
while the abundance of TAMs are associated
with poor prognosis.16 It seems that TAM is
recruited into tumor tissue before its conversion
to malignant.17
Several studies support that inflammatory
cells, especially TAM, secrete MMP-9 has
emerged as an important modulator of
angiogenesis and tumor development.4 MMP-9
is associated with degradation of the extra-
cellular matrix, including the basement
membrane. Disruption of basement membrane
integrity allows tumors to spread locally and
distantly.18 MMP-9 expression in this study was
correlated with histological grading, but not
with tumor stage. Pellikainen et al.19 found that
high expression of MMP-9 in carcinoma cells
was associated with a small tumor, whereas
positive stromal expression of MMP-9 was
associated with aggresive factors. It seems that
positive stromal expression of MMP-9 predicts
poor survival, whereas positive tumor cells
MMP-9 expression predicts favors survival.
Thus, evaluation of MMP-9 expression seems
to add valuable information on breast cancer
prognosis. Another study found no correlation
between the level of MMP-9 and histological
grading as well as cancer staging.20 Different
antibody and scoring system of protein
expression may highlight different results.
Many studies have proven that TAMs have
an important role in angiogenesis which can be
detected from MVD.Aresearch in breast cancer
found that MVD was correlated with the level
of TAM, being significantly higher in ductal
carcinoma with diffuse TAM infiltration than
tumor without TAM in the stroma.21 This study
showed similar result with several researches
that found a correlation of MVD with
histological grading and staging of breast
cancer,22,23 even though others found different
results.24,25 In the early stage of breast cancer,
MVD in the area containing high
neovascularization can be used as an
independent prognostic indicator of overall and
relapse-free survival.26 In male breast cancer,
MVD is not an independent prognostic factor.
As the age of diagnosis and tumor size increases,
the mortality of male breast cancer increases
as well.27
This study showed no significant correlat-
ion between VEGF expression with the
histological grade and stage. The highest
expression of VEGF was found in atypical
lesions (TABLE 2 and 3). This result supported
that angiogenic switch already started in early
grade and stage of breast cancer.28 A research
conducted by Bluff et al.17 found that there was
a significant increase of VEGF expressions
among benign, pre-invasive and invasive breast
cancer. It seems that angiogenic switch already
starts in the very early dysplastic breast lesion
and it has an important role in the progression
and invasion of cancer. Different result was
found by Shankar et al.29 which used MAGS
score as a method for counting of VEGF
expression. The method consists of
vasoproliferative score, endothelial cells
hyperplasia and endothelial cytology. A study
done by Leek et al.30 showed a significant
positive correlation between high vascular
grade of breast cancer with the increase of TAM
index and reduced relapse-free survival. In
colon cancer, there was no association between
VEGF expression and the survival, but the
increase of median survival had a relation with
VEGF-expressing TAM in the stroma. VEGF-
expressing TAM revealed an imbalanced anti-
tumor activation of macropages that was
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influenced by receptor flt-1 and induced by
MCP1. In colon cancer, VEGF-expressing TAM
was mostly found in stage II and III.31
Many studies propose that angiogenesis as
a new alternative treatment can be used to inhibit
the conversion of benign lession into malignant.
An in vivo angiogenic therapy such as linomide,
works by inhibiting the invasion of TAM into
the tumor nests and the production of TNF-,
whereas anti-epidermal growth factor (EGFR)
therapy can inhibit the activation of VEGF.32
CONCLUSION
This research shows a significant correlat-
ion between TAM, MVD and MMP-9 expressi-
ons among several histological progression,
histological grading and staging of breast cancer.
The highest expression of VEGF in atypical
breast lesion supports that angiogenic switch
already starts in early stage and grade of breast
cancer.
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